Home > Products > BAFF & IL17
> Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (scIgG)
Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (scIgG) (CAT#: SCIGG-019)
Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-BAFF and anti-IL17 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can neutralize both BAFF and IL- 17 simultaneously. It is designed for the research of Lupus Nephritis (LN); Systemic Lupus Erythematosus (SLE); Rheumatoid Arthritis (RA); Psoriasis (Ps); Ankylosing Spondylitis (AS); Psoriatic Arthritis (PA) primary Sjögren's Syndrome (pSS); Multiple Myeloma (MM) therapy.
There are currently no customer reviews or questions for Recombinant Anti-BAFF x Anti-IL17 Bispecific Antibody (scIgG) (SCIGG-019). Click the button below to contact us or submit your feedback about this product.